J Zhou, X Chu, J Zhao, M Xie, J Wu,
X Yu… - Biological Procedures …, 2023 - Springer
Background Clinical studies suggest that immune checkpoint inhibitor (ICI) monotherapy
has limited benefits in non-small cell lung cancer (NSCLC) patients after epidermal growth …